A New Generation of Artemesinin-based Combination Therapy (ACT) Antimalarial Drugs

ARCO^® (artemisinin and naphthoquine phosphate tablets) is a patented new antimalarial drug with proprietary intellectual property rights developed by the Chinese Academy of Military Medical Science (AMMS) and KPC, based on its experiences with compound artemether and lumefantrine tablets. ARCO® is not only efficient, safe, effective and has a high cure rate, and but is also able to cure uncomplicated malaria with only one single stat dose.

Each package contains 4 tablets with artemisnin 1000mg/ naphothoquine 400mg, each tablet contains artemisnin 250mg/ naphothoquine 100mg